These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18428025)

  • 1. Beneficial synergistic interactions of TNF-alpha and IL-6 in C2 skeletal myoblasts--potential cross-talk with IGF system.
    Al-Shanti N; Saini A; Faulkner SH; Stewart CE
    Growth Factors; 2008 Apr; 26(2):61-73. PubMed ID: 18428025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis.
    Foulstone EJ; Meadows KA; Holly JM; Stewart CE
    J Cell Physiol; 2001 Nov; 189(2):207-15. PubMed ID: 11598906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts.
    Meadows KA; Holly JM; Stewart CE
    J Cell Physiol; 2000 Jun; 183(3):330-7. PubMed ID: 10797307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro- and anti-apoptotic roles for IGF-I in TNF-alpha-induced apoptosis: a MAP kinase mediated mechanism.
    Saini A; Al-Shanti N; Faulkner SH; Stewart CE
    Growth Factors; 2008 Oct; 26(5):239-53. PubMed ID: 18651291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol.
    Saini A; Al-Shanti N; Sharples AP; Stewart CE
    Exp Physiol; 2012 Mar; 97(3):400-18. PubMed ID: 22125309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: relevance to disease and ageing?
    Sharples AP; Al-Shanti N; Stewart CE
    J Cell Physiol; 2010 Oct; 225(1):240-50. PubMed ID: 20506232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of insulin-like growth factor binding protein-3 (IGFBP-3) in the differentiation of primary human adult skeletal myoblasts.
    Foulstone EJ; Savage PB; Crown AL; Holly JM; Stewart CE
    J Cell Physiol; 2003 Apr; 195(1):70-9. PubMed ID: 12599210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNFalpha.
    Foulstone EJ; Huser C; Crown AL; Holly JM; Stewart CE
    Exp Cell Res; 2004 Mar; 294(1):223-35. PubMed ID: 14980516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
    Layne MD; Farmer SR
    Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifaceted roles of TNF-alpha in myoblast destruction: a multitude of signal transduction pathways.
    Stewart CE; Newcomb PV; Holly JM
    J Cell Physiol; 2004 Feb; 198(2):237-47. PubMed ID: 14603526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha.
    Fernández-Celemín L; Pasko N; Blomart V; Thissen JP
    Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1279-90. PubMed ID: 12388149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and validation of human prepubertal skeletal muscle cells: maturation and metabolic effects of IGF-I, IGFBP-3 and TNFalpha.
    Grohmann M; Foulstone E; Welsh G; Holly J; Shield J; Crowne E; Stewart C
    J Physiol; 2005 Oct; 568(Pt 1):229-42. PubMed ID: 16081485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of IL-6 on IGF-1 activity in skeletal myoblasts could be mediated by the activation of SOCS-3.
    Al-Shanti N; Stewart CE
    J Cell Biochem; 2012 Mar; 113(3):923-33. PubMed ID: 22033984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor.
    Shen WH; Zhou JH; Broussard SR; Freund GG; Dantzer R; Kelley KW
    Cancer Res; 2002 Aug; 62(16):4746-56. PubMed ID: 12183434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrovirally mediated overexpression of insulin-like growth factor binding protein 4: evidence that insulin-like growth factor is required for skeletal muscle differentiation.
    Damon SE; Haugk KL; Birnbaum RS; Quinn LS
    J Cell Physiol; 1998 Apr; 175(1):109-20. PubMed ID: 9491786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERK2 is required for efficient terminal differentiation of skeletal myoblasts.
    Li J; Johnson SE
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1425-33. PubMed ID: 16729973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL-6/sIL-6R treatment of a malignant melanoma cell line enhances susceptibility to TNF-alpha-induced apoptosis.
    Wagley Y; Yoo YC; Seo HG; Rhee MH; Kim TH; Kang KW; Nah SY; Oh JW
    Biochem Biophys Res Commun; 2007 Mar; 354(4):985-91. PubMed ID: 17274948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-5 potentiates the growth response of Caco-2 cells to IGF-II: a role in colonic carcinogenesis complicating ulcerative colitis?
    Makins R; Ballinger A
    Growth Horm IGF Res; 2005 Jun; 15(3):215-22. PubMed ID: 15935984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells.
    Pandini G; Genua M; Frasca F; Squatrito S; Vigneri R; Belfiore A
    Cancer Res; 2007 Sep; 67(18):8932-41. PubMed ID: 17875736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.